_______________________________________________________________________________________
Re: Global Case ID: TH201408008944 (Local Case ID: TH140803456), FU #2
Thank you for reporting to us a non-serious adverse event related to Lilly product(s).
We would like to collect more information to better understand the reported event.
Please respond to following questions regarding the adverse event – Numbness in leg and Unable to bend the knee, performed procedure: Surgery to implant three rods from hip to ankle, involving a Female patient, aged 63, who was subscribed Teriparatide, reported the event to Lilly on 22-Aug-2014.
Thank you.
Yours sincerely,
Sasithorn Suntharo
ELI LILLY AND COMPANY
Pharmacovigilance Associate
________________________________________________________________________
Please provide the information by 27-Apr-2015:
1. What was the reason for the surgery performed on 22Oct2014? Is there information available about the diagnosis of the case?
¬¬¬¬
2. Could the “numbness in leg” and “unable to bend the knee” be expected conditions after the surgery? Or should be considered adverse events? Was a corrective treatment introduced? Did the patient recover?
3. Does the physician have a relatedness opinion for the events? (Including Burning sensation in her chest, Dizziness, Bloating and Nausea, occurred prior to surgery)
4. What were the concomitant medications of patient?
Name of HCP/ Initial Reporter:
Signature:
Date:
__________________________________________________________________________________
For Eli Lilly Internal Use Only
Reporter (Name and Designation):
Date of Confirmation of FU request sent to HCP:
For Asia PhV Central Office Use Only:
Awareness Date (dd/mmm/yyyy) of this FU report:
Information received from:
☐ Call Centre
☐ Sales Representative
☐ Others, please specify:_____________________________
Method of information received:
☐ email (Please attach the email for documentation)
☐ Hard Copy
☐ Call (Please attach the communication log for documentation)
☐ Others, please specify: ______________________